Evidence map›Paper›PMID 42037754›Full record

ArticleEJHaem2026

Sequential Analysis of Murine Myelofibrosis Models Using a Novel Deep Learning-Based Fibrosis Quantitative Method.

Toshikuni Kawamura, Takaaki Maekawa, Keita Kouzu, Hiraku Ogata, Noriaki Tachi, Shoichiro Kato, Yukiko Osawa, Takahiro Einama, Kimiya Sato, Shinichi Kobayashi

Abstract read
In one paragraph

Article in EJHaem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Toshikuni KawamuraDivision of Hematology Department of Internal Medicine National Defense Medical College Tokorozawa Saitama Japan.
Takaaki MaekawaDivision of Hematology Department of Internal Medicine National Defense Medical College Tokorozawa Saitama Japan.ORCID https://orcid.org/0000-0002-8611-0862
Keita KouzuDepartment of Surgery National Defense Medical College Tokorozawa Saitama Japan.
Hiraku OgataDivision of Hematology Department of Internal Medicine National Defense Medical College Tokorozawa Saitama Japan.
Noriaki TachiDivision of Hematology Department of Internal Medicine National Defense Medical College Tokorozawa Saitama Japan.
Shoichiro KatoDivision of Hematology Department of Internal Medicine National Defense Medical College Tokorozawa Saitama Japan.
Yukiko OsawaDivision of Hematology Department of Internal Medicine National Defense Medical College Tokorozawa Saitama Japan.
Takahiro EinamaDepartment of Surgery National Defense Medical College Tokorozawa Saitama Japan.
Kimiya SatoDepartment of Basic Pathology National Defense Medical College Tokorozawa Saitama Japan.
Shinichi KobayashiDivision of Hematology Department of Internal Medicine National Defense Medical College Tokorozawa Saitama Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Primary myelofibrosis (MF) is characterized by MF, splenomegaly, and extramedullary hematopoiesis. MF initially presents with reticular fibers (RFs) and progresses to increased collagen fiber deposition in the advanced stages. Although recent clinical trials have adopted MF improvement as an evaluation criterion, current diagnostic methods rely primarily on qualitative assessments based on the presence or absence of reticular and collagen fibers. Therefore, detecting subtle changes during the early stages of MF can be challenging. Methods: We developed a novel deep learning-based method for quantitatively evaluating MF by measuring RFs as an indicator. Unlike collagen fibers, RFs are detectable from the early stages of MF and increase as the disease progresses. Moreover, based on the hypothesis that splenic fibrosis progresses in parallel with MF, we applied this method to evaluate RFs in the spleen. Using these methods, we analyzed temporal changes in fibrosis, splenomegaly, and hematopoietic stem cell dynamics over time in two MF models: a drug-induced fibrosis model using romiplostim and a Results: Our findings revealed that in Conclusion: Our novel deep learning-based method successfully captured temporal changes in bone marrow and spleen fibrosis and shows potential for clinical application. Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.

Indexed as

deep learningextramedullary hematopoiesishematopoietic stem cellJAK2V617F mutationprimary myelofibrosisreticular fiberssplenomegaly

Identifiers

PMID42037754
PMCPMC13108711

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.